13913-012-02 |
13913-012 |
HUMAN PRESCRIPTION DRUG |
Cambia |
diclofenac potassium |
POWDER, FOR SOLUTION |
ORAL |
20160310 |
N/A |
NDA |
NDA022165 |
Assertio Therapeutics, Inc. |
DICLOFENAC POTASSIUM |
50 mg/1 |
9 PACKET in 1 CARTON (13913-012-02) / 1 POWDER, FOR SOLUTION in 1 PACKET |
13913-012-03 |
13913-012 |
HUMAN PRESCRIPTION DRUG |
Cambia |
diclofenac potassium |
POWDER, FOR SOLUTION |
ORAL |
20160310 |
N/A |
NDA |
NDA022165 |
Assertio Therapeutics, Inc. |
DICLOFENAC POTASSIUM |
50 mg/1 |
9 PACKET in 1 CARTON (13913-012-03) / 1 POWDER, FOR SOLUTION in 1 PACKET (13913-012-01) |
13913-011-19 |
13913-011 |
HUMAN PRESCRIPTION DRUG |
Cambia |
diclofenac potassium |
POWDER, FOR SOLUTION |
ORAL |
20100420 |
N/A |
NDA |
NDA022165 |
Assertio Therapeutics, Inc. |
DICLOFENAC POTASSIUM |
50 mg/1 |
9 PACKET in 1 CARTON (13913-011-19) / 1 POWDER, FOR SOLUTION in 1 PACKET (13913-011-01) |
69315-506-09 |
69315-506 |
HUMAN PRESCRIPTION DRUG |
DICLOFENAC POTASSIUM |
DICLOFENAC POTASSIUM |
POWDER, FOR SOLUTION |
ORAL |
20221220 |
N/A |
NDA AUTHORIZED GENERIC |
NDA022165 |
Leading Pharma, LLC |
DICLOFENAC POTASSIUM |
50 mg/1 |
9 PACKET in 1 CARTON (69315-506-09) / 1 POWDER, FOR SOLUTION in 1 PACKET |